Blog

Notes from the Aesthetic Meeting

April 26, 2010

Investors, The feedback from our sales and marketing team at the aesthetic plastic surgery meeting this past weekend, where PureGraft™ was launched, has been extremely positive. One of the most relevant trends and observations coming out of the meeting is the influence fat grafting is starting to have on the industry. Fortunately for Cytori, this has translated into significant interest amongst surgeons at the conference in the PureGraft™ product, our Celbrush™ micro-droplet adipose delivery  tool, and in our Celution® System, which was on display as part of our U.S. development pipeline.

For Cytori, quality and innovation of products aside, we don’t underestimate being in the right place, or in this case the right market, at the right time. Perhaps it’s a bit serendipitous, yet fortuitous for Cytori nonetheless, that fat grafting is an emerging growth area in plastic surgery.  We can address this market  today with PureGraft™ and expect to further grow this market in the future with Celution®.

For those of you looking for more details on PureGraft™, such as its attributes, product pricing, or how it’s bundled, we encourage you to have a look at our new e-commerce site at www.puregraft.com.
Tags: No tags
Categories: No categories
 
About This Blog
Visit our shareholder blog to get periodic updates on our company and products as well as occasional commentary on industry developments impacting our business. Members of management as well as other employees will also provide candid insight from time time. Enjoy, Tom

Blog entiries include forward-looking statements regarding events, trends and business prospects, which may affect our future operating results and financial position. Such statements are subject to risks and uncertainties that could cause our actual results and financial position to differ materially. Some of these risks and uncertainties are described under the "Risk Factors" in Cytori's Securities and Exchange Filings, including its annual report on Form 10-K. Cytori assumes no responsibility to update or revise any forward-looking statements contained in these notes to reflect events, trends or circumstances after the date of these blog entries.

Links to external websites and news and information sources may at times be provided. Any information, views or opinions expressed in these links do not necessarily represent the views of Cytori, nor can Cytori ensure the accuracy of any information contained in external links, in particular is it might relate to Cytori.
Recent Posts
RSS Feed


Close window | Back to top


Copyright 2010 Cytori Therapeutics